ArticleScience progress2021
A method to construct key success factors in the cell therapy industry.
Article in Science progress, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the field of regenerative medicine, cell therapy is often used to regenerate organs or tissue that can be widely applied to several diseases. In recent years, the Taiwanese government has listed the biotechnology industry as a key developmental objective and has enacted laws to regulate cell therapy. This has led to substantial change and has necessitated a reliable direction of management in the cell therapy industry. Therefore, this study aims to develop a new method to explore the key success factors in three dimensions of relevant biotechnology company management. It adopts a qualitative method combined with a quantitative analysis method. The study uses Gwo Xi Stem Cell Company, a qualified cell therapy company in Taiwan, as a case study. It adopts a literature analysis method and conducts interviews with cell therapy experts to develop an innovative assessment framework. The analytic hierarchy process is combined with decision-making trial and evaluation laboratory to establish the key success factors in the management of the cell therapy industry. Thus, the study offers strategic recommendations for the development of domestic stem-cell-related industries. The results demonstrate technical characteristics as the most important direction for successful management. Moreover, due to the substantial change in Taiwan's cell therapy industry, technical characteristic-related key success factors, including product development strategy (technical characteristic 1) and technological mastery (technical characteristic 2), are currently considered to be crucial key success factors in decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.